Clinical Trials on Prostate Cancer With Intermediate Risk
Total 6147 results
-
UMC UtrechtRadboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; The...CompletedProstate Cancer AdenocarcinomaNetherlands, Belgium
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
Sharp HealthCareWithdrawnMetastatic Prostate CancerUnited States
-
Baylor College of MedicineCompletedLocalized Prostate CancerUnited States
-
DexTech Medical ABTerminatedProstate Cancer MetastaticSweden
-
SCRI Development Innovations, LLCNovartisWithdrawnAdvanced Prostate CancerUnited States
-
Centre Jean PerrinCompletedMetastatic Prostate CancerFrance
-
University Hospital, RouenCompleted
-
University of Colorado, DenverCompletedProstate Cancer ScreeningUnited States
-
University of FloridaWithdrawnMetastatic Prostate Cancer
-
Georgetown UniversityU.S. Army Medical Research and Development CommandCompleted
-
Lahey ClinicTerminated
-
Thomas Jefferson UniversityRecruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Soft Tissue MetastasesUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Novartis PharmaceuticalsCompletedProstate Cancer With Bone Metastasis
-
Roswell Park Cancer InstituteActive Biotech ABCompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
Alliance Foundation Trials, LLC.BayerRecruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Castrate Resistant Prostate CancerUnited States
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedMetastatic Prostate Cancer | Castration Resistant Prostatic CancerUnited States
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsRecruitingRecurrent Prostate Cancer | Metastatic Prostate CancerFinland, Norway, Estonia, Denmark
-
Marmara UniversityRecruitingProstatic Neoplasms | Prostate Cancer | Prostate Adenocarcinoma | Prostate Disease | Prostate Cancer StageTurkey
-
Jonsson Comprehensive Cancer CenterJanssen Scientific Affairs, LLCRecruitingProstate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8United States
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Hormone-Resistant Prostate CancerCanada
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Metastatic Prostatic Adenocarcinoma | Metastatic Prostate Carcinoma in the Soft TissueCanada
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeSuspendedProstate Cancer | Prostate NeoplasmUnited Kingdom
-
National Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
Mayo ClinicRecruitingProstate Cancer | Prostate Adenocarcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLCRecruitingCastration-resistant Prostate CancerUnited Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedStage IV Prostate CancerUnited States
-
Stanford UniversityWithdrawnProstate Cancer | Castrate Resistant Prostate Cancer
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
Terence Friedlander, MDJanssen Biotech, Inc.CompletedCastration Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer | Castration-resistant Prostate CancerChina
-
Hellenic Cooperative Oncology GroupSanofiCompletedBone Metastatic Prostate CancerGreece
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownCastration-resistant Prostate Cancer
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
Sunnybrook Health Sciences CentreSunnybrook Research InstituteUnknownCastrate Resistance Prostate Cancer
-
Hoffmann-La RocheCompleted
-
Spanish Oncology Genito-Urinary GroupAstellas Pharma Inc; Apices Soluciones S.L.CompletedHormone-refractory Prostate CancerSpain
-
Peking UniversityWithdrawnHormone Refractory Prostate CancerChina
-
Exact ImagingCompletedProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateCanada, United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnStage III Prostate Cancer
-
Consorzio OncotechUnknownProstate Cancer | Castration-resistant Prostate CancerItaly